These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
140 related articles for article (PubMed ID: 35362132)
1. Letter: inflammatory bowel disease services during the Covid-19 pandemic - authors' reply. Deputy M; Hart A; Faiz O Aliment Pharmacol Ther; 2022 Apr; 55(8):1064. PubMed ID: 35362132 [TBL] [Abstract][Full Text] [Related]
2. Letter: inflammatory bowel disease services during the Covid-19 pandemic. Mungmunpuntipantip R; Wiwanitkit V Aliment Pharmacol Ther; 2022 Apr; 55(8):1063. PubMed ID: 35362136 [TBL] [Abstract][Full Text] [Related]
3. Letter: paying attention to the comorbidities or extraintestinal complications in patients with inflammatory bowel disease during the COVID-19 pandemic-authors' reply. Hadi Y; Kochhar GS Aliment Pharmacol Ther; 2022 Jul; 56(1):178. PubMed ID: 35689315 [TBL] [Abstract][Full Text] [Related]
4. Management of patients with inflammatory bowel disease and outcomes during the first wave of the Covid-19 pandemic. Viola A; Giambò F; Chiappetta MF; Costantino G; Pallio S; Fries W Dig Liver Dis; 2021 Jun; 53(6):689-690. PubMed ID: 33832871 [No Abstract] [Full Text] [Related]
5. Letter: IBD nurse-pivotal role in the time of the pandemic. Authors' reply. Al-Ani AH; Rentsch CA; Azim S; Bidgood E; Onasseril P; Christensen B Aliment Pharmacol Ther; 2020 Aug; 52(4):746-747. PubMed ID: 32886366 [No Abstract] [Full Text] [Related]
6. Letter: paying attention to the comorbidities or extraintestinal complications in patients with inflammatory bowel disease during the COVID-19 pandemic. Yuan WQ; Li F; Yang LC; Yang ZL; Cui DJ Aliment Pharmacol Ther; 2022 Jun; 55(11):1464-1465. PubMed ID: 35538353 [TBL] [Abstract][Full Text] [Related]
7. Inflammatory Bowel Disease and the SARS-CoV-2 Pandemic: More Speed, Less Haste. Gower-Rousseau C; Fumery M; Pariente B; Gastroenterology; 2021 Jan; 160(1):473-474. PubMed ID: 32389663 [No Abstract] [Full Text] [Related]
8. Letter: SARS-CoV-2 infection in two inflammatory bowel disease patients treated with dual targeted therapy-Authors' reply. Al-Ani AH; Prentice RE; Rentsch C; Christensen B Aliment Pharmacol Ther; 2021 Mar; 53(6):766-767. PubMed ID: 33599326 [No Abstract] [Full Text] [Related]
9. Letter: association between COVID-19 and inflammatory bowel disease-Authors' reply. Hadi Y; Kochhar GS Aliment Pharmacol Ther; 2022 May; 55(9):1228-1229. PubMed ID: 35429037 [TBL] [Abstract][Full Text] [Related]
10. Emotional state should not be used to differentiate IBD from IBS - Authors' reply. Iacucci M; Cannatelli R; Labarile N; Ghosh S Lancet Gastroenterol Hepatol; 2020 Aug; 5(8):723-724. PubMed ID: 32673606 [No Abstract] [Full Text] [Related]
11. The COVID-19 pandemic shows us in which way the care of patients with inflammatory bowel disease should move. Hernández Ramírez V; López Serrano P Rev Esp Enferm Dig; 2021 Feb; 113(2):153-154. PubMed ID: 33467860 [TBL] [Abstract][Full Text] [Related]
12. Providing Guidance During a Global Viral Pandemic for the Care of Patients With Inflammatory Bowel Disease. Abreu MT; Peyrin-Biroulet L J Crohns Colitis; 2020 Oct; 14(14 Suppl 3):S767-S768. PubMed ID: 33085969 [No Abstract] [Full Text] [Related]
13. Practical management of inflammatory bowel disease patients during the COVID-19 pandemic: expert commentary from the Gastroenterological Society of Australia Inflammatory Bowel Disease faculty. Aysha AA; Rentsch C; Prentice R; Johnson D; Bryant RV; Ward MG; Costello SP; Lewindon P; Ghaly S; Connor SJ; Begun J; Christensen B Intern Med J; 2020 Jul; 50(7):798-804. PubMed ID: 32656985 [TBL] [Abstract][Full Text] [Related]
14. Inflammatory bowel disease and SARS-CoV-2 pandemic: current knowledge and recommendations. Bekic D; Belosic Halle Z Scand J Gastroenterol; 2021 Jun; 56(6):656-660. PubMed ID: 33765405 [TBL] [Abstract][Full Text] [Related]
15. Editorial: COVID-19 vaccines are safe and effective in patients with inflammatory bowel disease-but many unanswered questions remain. Authors' reply. Bhurwal A; Mutneja H; Seril D Aliment Pharmacol Ther; 2022 Jul; 56(1):164-165. PubMed ID: 35689313 [TBL] [Abstract][Full Text] [Related]
16. Commenting on the Letter (Completing the Picture in Egypt: Response to "Inflammatory Bowel Diseases in Egypt During the COVID-19 Pandemic"). Eltabbakh M; Abd Alaty W; Sakr MA; Sherief AF Inflamm Bowel Dis; 2021 Apr; 27(5):e66. PubMed ID: 33512507 [No Abstract] [Full Text] [Related]
17. Therapeutic Decisions in Inflammatory Bowel Disease in the SARS-Cov-2 Pandemic. Brain O; Satsangi J Gastroenterology; 2021 Apr; 160(5):1883-1884. PubMed ID: 32553759 [No Abstract] [Full Text] [Related]
18. Long-Term Impact of the COVID-19 Pandemic on Inflammatory Bowel Disease Healthcare Utilization: A 2-Year Nationwide Update. Derks MEW; van Lierop LMA; Te Groen M; Kuijpers CCHJ; Nagtegaal ID; Hoentjen F Inflamm Bowel Dis; 2024 Jan; 30(1):146-149. PubMed ID: 37000678 [No Abstract] [Full Text] [Related]
19. Editorial: increasing IBD prevalence and its complications in the context of the COVID-19 pandemic. Authors' reply. King DS; Trudgill NJ; Adderley NJ Aliment Pharmacol Ther; 2020 Jun; 51(12):1442-1443. PubMed ID: 32406090 [No Abstract] [Full Text] [Related]
20. Assessing the repercussions of COVID-19 pandemic on symptoms, disease management, and emotional well-being in patients with inflammatory bowel disease: a multi-site survey study. El-Dallal M; Saroufim A; Systrom H; Ballou S; Farhoud A; Pasam RT; Gadupudi SS; Osman K; Chaudrey K; Cheifetz A; Feuerstein JD Scand J Gastroenterol; 2022 Apr; 57(4):406-414. PubMed ID: 34894999 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]